DNAJC2 and breast carcinoma: This study aims to confirm cancer-related serological profile of ZRF1 and KRR1 in large-scale ELISA screening of their recombinant analogues with sera of breast cancer patients of different histological types and tumor grades compared with sera of healthy individuals.